论文部分内容阅读
目的:探讨肠内营养(EN)在胎儿生长受限(FGR)孕妇的临床应用效果。方法:对孕30~32周FGR初产单胎无其他合并症孕妇70例按入院时间进行编号,单号为观察组(n=35),双号为对照组(n=35)。在治疗FGR过程中两组热量、各营养素相同情况下加餐饮食应用整蛋白型制剂能全素750ml为观察组,应用普通食物为对照组;测定两组治疗前后孕妇的宫高、腹围、体重及胎儿双顶径(BPD)、头围(HC)、腹围(AC)、股骨长(FL),然后统计其增长值进行比较。结果:观察组孕妇的宫高、腹围、体重及胎儿的BPD、HC、AC、FL增长均优于对照组,差异有统计学意义(P<0.05)。结论:在FGR孕妇中的应用EN有利于胎儿生长发育。
Objective: To investigate the clinical effect of enteral nutrition (EN) in pregnant women with fetal growth restriction (FGR). Methods: 70 pregnant women with uncomplicated FGR primiparity at first trimester of pregnancy were enrolled in the study. The single was the observation group (n = 35) and the double was the control group (n = 35). In the treatment of FGR process, two groups of calories, the same nutrients under the same diet dining diet protein whole veterinary preparation 750ml for the observation group, the application of normal food as the control group; measured before and after treatment in both groups of women’s uterus, abdominal circumference, Body weight and fetus biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), femur length (FL), and then statistics the growth value for comparison. Results: The uterine height, abdominal circumference, body weight and fetus BPD, HC, AC, FL growth in the observation group were better than the control group, the difference was statistically significant (P <0.05). Conclusion: The application of EN in pregnant women with FGR is good for fetal growth and development.